FDA Action Update, January 2026: Approvals, Acceptance, and Clearance NeurologyLive Clinical Neurology News and Neurology Expert Insights GHK Cu Copper Peptide Research Compound Drexa Labs Nine Anticipated FDA Approvals for January 2026 Guideline Central The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Buy GHK Cu 50mg 99% Purity Made in USA Peptide